These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21129964)

  • 1. Discovery and optimisation of a selective non-steroidal glucocorticoid receptor antagonist.
    Brown AR; Bosies M; Cameron H; Clark J; Cowley A; Craighead M; Elmore MA; Firth A; Goodwin R; Goutcher S; Grant E; Grassie M; Grove SJ; Hamilton NM; Hampson H; Hillier A; Ho KK; Kiczun M; Kingsbury C; Kultgen SG; Littlewood PT; Lusher SJ; Macdonald S; McIntosh L; McIntyre T; Mistry A; Morphy JR; Nimz O; Ohlmeyer M; Pick J; Rankovic Z; Sherborne B; Smith A; Speake M; Spinks G; Thomson F; Watson L; Weston M
    Bioorg Med Chem Lett; 2011 Jan; 21(1):137-40. PubMed ID: 21129964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification a novel, selective, non-steroidal, functional glucocorticoid receptor antagonist.
    Rimland J; Dunne A; Hunjan SS; Sasse R; Uings I; Montanari D; Caivano M; Shah P; Standing D; Gray D; Brown D; Cairns W; Trump R; Smith PW; Bertheleme N; D'Alessandro P; Gul S; Vimal M; Smith DN; Watson SP
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2340-3. PubMed ID: 20202837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation.
    Edman K; Ahlgren R; Bengtsson M; Bladh H; Bäckström S; Dahmén J; Henriksson K; Hillertz P; Hulikal V; Jerre A; Kinchin L; Kåse C; Lepistö M; Mile I; Nilsson S; Smailagic A; Taylor J; Tjörnebo A; Wissler L; Hansson T
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2571-7. PubMed ID: 24755427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.
    Ray NC; Clark RD; Clark DE; Williams K; Hickin HG; Crackett PH; Dyke HJ; Lockey PM; Wong M; Devos R; White A; Belanoff JK
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4901-5. PubMed ID: 17587578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of novel bile-acid conjugated glucocorticoid receptor antagonists.
    Richards SJ; von Geldern TW; Jacobson P; Wilcox D; Nguyen P; Ohman L; Osterlund M; Gelius B; Grynfarb M; Goos-Nilsson A; Wang J; Fung S; Kalmanovich M
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6086-90. PubMed ID: 16987661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists.
    Akritopoulou-Zanze I; Patel JR; Hartandi K; Brenneman J; Winn M; Pratt JK; Grynfarb M; Goos-Nisson A; Von Geldern TW; Kym PR
    Bioorg Med Chem Lett; 2004 May; 14(9):2079-82. PubMed ID: 15080982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a potent series of non-steroidal non α-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicity.
    Diallo H; Angell DC; Barnett HA; Biggadike K; Coe DM; Cooper TW; Craven A; Gray JR; House D; Jack TI; Keeling SP; Macdonald SJ; McLay IM; Oliver S; Taylor SJ; Uings IJ; Wellaway N
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1126-33. PubMed ID: 21257309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists.
    Clark RD; Ray NC; Blaney P; Crackett PH; Hurley C; Williams K; Dyke HJ; Clark DE; Lockey PM; Devos R; Wong M; White A; Belanoff JK
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5704-8. PubMed ID: 17822897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist.
    Jiang W; Fiordeliso JJ; Allan G; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Sui Z
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1471-4. PubMed ID: 17258455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists.
    Baxter A; Cooper A; Kinchin E; Moakes K; Unitt J; Wallace A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):960-3. PubMed ID: 16297626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel non-steroidal glucocorticoid receptor antagonist.
    Li QY; Zhang M; Hallis TM; Derosier TA; Yue JM; Ye Y; Mais DE; Wang MW
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1531-6. PubMed ID: 20035723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,3-diaminopropan-2-ol sulfonamides as potent and selective inhibitors of the glycine transporter type 1.
    Rahman SS; Coulton S; Herdon HJ; Joiner GF; Jin J; Porter RA
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1741-5. PubMed ID: 17234406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydroquinoline glucocorticoid receptor agonists: discovery of a 3-hydroxyl for improving receptor selectivity.
    Roach SL; Higuchi RI; Hudson AR; Adams ME; Syka PM; Mais DE; Miner JN; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2011 Jan; 21(1):168-71. PubMed ID: 21115247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity.
    Clark RD; Ray NC; Williams K; Blaney P; Ward S; Crackett PH; Hurley C; Dyke HJ; Clark DE; Lockey P; Devos R; Wong M; Porres SS; Bright CP; Jenkins RE; Belanoff J
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1312-7. PubMed ID: 18226897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of liver selective non-steroidal glucocorticoid receptor antagonist as novel antidiabetic agents.
    Shah K; Patel D; Jadav P; Sheikh M; Sairam KV; Joharapurkar A; Jain MR; Bahekar R
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5857-62. PubMed ID: 22917520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists.
    Yates CM; Brown PJ; Stewart EL; Patten C; Austin RJ; Holt JA; Maglich JM; Angell DC; Sasse RZ; Taylor SJ; Uings IJ; Trump RP
    J Med Chem; 2010 Jun; 53(11):4531-44. PubMed ID: 20469868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-methyltryptamine sulfonamide derivatives as novel glucocorticoid receptor ligands.
    Marshall DR; Rodriguez G; Thomson DS; Nelson R; Capolina A
    Bioorg Med Chem Lett; 2007 Jan; 17(2):315-9. PubMed ID: 17118655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids).
    Biju P; McCormick K; Aslanian R; Berlin M; Solomon D; Wang H; Lee YJ; Bitar R; Prelusky D; McLeod R; Jia Y; Fernandez X; Eckel S; House A; Lieber G; Jimenez J; Kelly G; Chapman R; Phillips J; Anthes J
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1086-90. PubMed ID: 22197391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity.
    Vachal P; Fletcher JM; Fong TM; Huang CC; Lao J; Xiao JC; Shen CP; Strack AM; Shearman L; Stribling S; Chen RZ; Frassetto A; Tong X; Wang J; Ball RG; Tsou NN; Hickey GJ; Thompson DF; Faidley TD; Nicolich S; Achanfuo-Yeboah J; Hora DF; Hale JJ; Hagmann WK
    J Med Chem; 2009 Apr; 52(8):2550-8. PubMed ID: 19320488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.
    Brugel TA; Smith RW; Balestra M; Becker C; Daniels T; Hoerter TN; Koether GM; Throner SR; Panko LM; Folmer JJ; Cacciola J; Hunter AM; Liu R; Edwards PD; Brown DG; Gordon J; Ledonne NC; Pietras M; Schroeder P; Sygowski LA; Hirata LT; Zacco A; Peters MF
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5847-52. PubMed ID: 20727752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.